October 01, 2021: Prime Minister Imran Khan on Friday directed the authorities concerned to take steps to exploit the full potential of exports diversification in the salt and pharmaceutical sectors.
Chairing a meeting of National Export Development Board, the prime minister said the government was focused on creating business-friendly environment in the country for further strengthening the economy and increasing employment opportunities.
The prime minister emphasized that business community should adopt modern technologies to achieve maximum value addition.
The meeting was attended by Finance Minister Shaukat Tareen, Minister for Industries and Production Khusro Bakhtiar, Commerce Advisor Abdul Razak Dawood, Special Assistant to PM on Health Dr Faisal Sultan, SAPM on Political Communication Dr Shahbaz Gill, CEO Drug Regulatory Authority of Pakistan (DRAP) Asim Rauf, representatives of pharmaceutical and salt sectors and senior officials.
The Prime Minister was briefed on the potential of diversification of exports, especially in the salt and pharmaceutical sectors.
He was briefed that Pakistan was blessed with all types of salt available in the world including rock salt, sea salt and lake salt.
With a reserve size of 6.2 billion tons, Khewra Salt Mine is the second largest salt range in the world. Pakistan has also sea salt reserves along 1,050 kilometre long coastline.
Almost 60 percent of total 350 million tons global salt consumption is made by the chemical industry.
Pakistan’s current annual salt production is four million tons, whereas just 0.3 million tons are being exported each year.
The government of Balochistan and Hub Salt has initiated a new Solar Salt project to tap Pakistan’s huge potential in salt export. This new Solar Salt Project will be the world’s largest salt works facility and will boost salt exports by $400 million in 2023 and will continue to grow by $200 million per annum in subsequent years.
Moreover, it was told that currently Pakistan’s pharmaceutical exports are worth $275 million with a growth potential of $74.3 billion. This growth potential can be materialized by investing in the machinery and equipment, streamlining the registration process for Pakistani medicines, entering into joint ventures with reputed multinational companies, and appointing sales and marketing teams in international markets for brand building.
APP
27200
